BAY 869766,
BAY-869766,
BAY869766,
N-(3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-6-methoxyphenyl)-1-(2,3-dihydroxypropyl)cyclopropane-1-sulfonamide,
RDEA 119,
RDEA-119,
RDEA119,
refametinib,
Refametinib R-Enantiomer,
923032-38-6,
Refametinib R enantiomer,
SCHEMBL345334,
CHEMBL3349342,
SCHEMBL10314890,
RDSACQWTXKSHJT-UHFFFAOYSA-N,
HMS3654O17,
NCGC00229510-01,
NCGC00229510-02,
AK548109,
n-(3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-6-methoxyphenyl)-1-(2,3-dihydroxypropyl) cyclopropane-1-sulfonamide,
N-(3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-6-methoxyphenyl)-1-(2,3-dihydroxypropyl)cyclopropane-1-sulfonamide,
Refametinib,
RDEA119,
BAY 869766,
923032-37-5,